HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized ...
Everest Medicines today announced that it has entered into an Asset Purchase Agreement with Corxel Pharmaceuticals Hong Kong Limited. Under the agreement, the Company has acquired the rights to ...
Everest Medicines inks Asset Purchase Agreement with Corxel to develop and commercialize Cardamyst nasal spray in Greater China: Shanghai, China Tuesday, March 24, 2026, 16:00 Hrs ...
Everest Medicines (HKEX 1952.HK, Everest, or the Company), a biopharmaceutical company focused on the discovery, clinical ...
FDA approval of CARDAMYST represents first new option in 30 years for the more than two million patients with PSVTParticipants using CARDAMYST in clinical studies were 2x more likely to convert ...
Milestone Pharmaceuticals (NASDAQ:MIST) executives highlighted the company’s transition to commercialization during a ...
Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc ...
Background Pericardium is considered electrically inert, but diffuse ST-elevation is an electrocardiographic marker of acute ...
Milestone Pharmaceuticals, a leading pharmaceutical company, marked a significant milestone in its journey by securing FDA ...
In a recent conference call to discuss its Q4 2025 and full year 2025 earnings, Alvotech outlined its plans for continued ...
The UAB Department of Otolaryngology–Head and Neck Surgery is an integral part of one of the nation's largest health systems. Nationally known for our compassionate care, cutting-edge research, and ...